Epigallocatechin gallate (EGCG) can epigenetically regulate the receptor of advanced glycation end products (RAGE) to ameliorate Osteoarthritis
Journal of Functional Foods · 2023-08 · 107 · 105682
DOI: 10.1016/j.jff.2023.105682 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Functional Foods, 2023-08. Verfasst von Xiaoqing Wu und 3 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shanxi Provincial Key Research and Development Project, National Natural Science Foundation of China, Foundation for Distinguished Young Talents in Higher Education of Guangdong.
Abstract (Originalsprache)
Epigallocatechin-3-O-gallate is natural phytochemical of green tea. RAGE upregulation promotes osteoarthritis (OA) progression. Herein, we revealed that EGCG can repress RAGE expression epigenetically to ameliorate OA. Firstly we found that RAGE expression was dose-dependently reduced by EGCG on chondrocyte cell C28/I2. EGCG also suppressed RAGE in human primary OA chondrocytes, and accordingly attenuated ROS production and NF-κb activity. Osteoarthritic microenvironment was also improved by EGCG, which was reflected by the enhanced chondrogenic markers and reduced inflammatory markers. EGCG-induced ameliorations were counteracted by artificial overexpression of RAGE. Additionally, EGCG modulates RAGE expression not only by its antioxidant activity, but also by facilitating RAGE promoter hypermethylation. To confirm this epigenetic modification, we employed dCAS9-Tet1 against EGCG’s epigenetic regulation. RAGE level was correspondingly rescued after EGCG-induced hypermethylation status were blocked. These findings support therapeutic roles of EGCG on OA and uncover the novel molecular mechanism of EGCG-mediated RAGE modulation.
Förderung
- Shanxi Provincial Key Research and Development Project
- National Natural Science Foundation of China
- Foundation for Distinguished Young Talents in Higher Education of Guangdong
Zitieren
APA
Wu, X., Shi, X., Chen, X., & Yin, Z. (2023). Epigallocatechin gallate (EGCG) can epigenetically regulate the receptor of advanced glycation end products (RAGE) to ameliorate Osteoarthritis. Journal of Functional Foods, 107, 105682. https://doi.org/10.1016/j.jff.2023.105682
Vancouver
Wu X, Shi X, Chen X, Yin Z. Epigallocatechin gallate (EGCG) can epigenetically regulate the receptor of advanced glycation end products (RAGE) to ameliorate Osteoarthritis. Journal of Functional Foods. 2023;107:105682. doi:10.1016/j.jff.2023.105682
BibTeX
@article{Wu2023,
author = {Wu, Xiaoqing and Shi, Xuanren and Chen, Xiaoyong and Yin, Zhanhai},
title = {Epigallocatechin gallate (EGCG) can epigenetically regulate the receptor of advanced glycation end products (RAGE) to ameliorate Osteoarthritis},
journal = {Journal of Functional Foods},
year = {2023},
volume = {107},
pages = {105682},
doi = {10.1016/j.jff.2023.105682}
}
EUVIMED